1. Home
  2. CPIX vs FGL Comparison

CPIX vs FGL Comparison

Compare CPIX & FGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • FGL
  • Stock Information
  • Founded
  • CPIX 1999
  • FGL 2021
  • Country
  • CPIX United States
  • FGL Malaysia
  • Employees
  • CPIX N/A
  • FGL N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • FGL
  • Sector
  • CPIX Health Care
  • FGL
  • Exchange
  • CPIX Nasdaq
  • FGL NYSE
  • Market Cap
  • CPIX 37.9M
  • FGL 33.2M
  • IPO Year
  • CPIX 2009
  • FGL 2024
  • Fundamental
  • Price
  • CPIX $2.53
  • FGL $1.87
  • Analyst Decision
  • CPIX
  • FGL
  • Analyst Count
  • CPIX 0
  • FGL 0
  • Target Price
  • CPIX N/A
  • FGL N/A
  • AVG Volume (30 Days)
  • CPIX 509.3K
  • FGL 1.1M
  • Earning Date
  • CPIX 03-04-2025
  • FGL 12-17-2024
  • Dividend Yield
  • CPIX N/A
  • FGL N/A
  • EPS Growth
  • CPIX N/A
  • FGL 45.69
  • EPS
  • CPIX N/A
  • FGL 0.04
  • Revenue
  • CPIX $36,785,442.00
  • FGL $23,268,519.00
  • Revenue This Year
  • CPIX N/A
  • FGL N/A
  • Revenue Next Year
  • CPIX N/A
  • FGL N/A
  • P/E Ratio
  • CPIX N/A
  • FGL $49.55
  • Revenue Growth
  • CPIX N/A
  • FGL 336.06
  • 52 Week Low
  • CPIX $1.04
  • FGL $1.25
  • 52 Week High
  • CPIX $3.93
  • FGL $5.26
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 59.45
  • FGL N/A
  • Support Level
  • CPIX $2.21
  • FGL N/A
  • Resistance Level
  • CPIX $3.93
  • FGL N/A
  • Average True Range (ATR)
  • CPIX 0.33
  • FGL 0.00
  • MACD
  • CPIX -0.00
  • FGL 0.00
  • Stochastic Oscillator
  • CPIX 20.00
  • FGL 0.00

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About FGL FOUNDER GROUP LTD

Founder Group Ltd acts as an end-to-end Engineering, Procurement, Construction, and Commissioning solutions provider for solar PV facilities in Malaysia. The segments of the company are large-scale solar projects and commercial and industrial (C&I) solar projects. Large-scale solar projects of the company are utility-scale solar PV power plants with installed generating capacity of 1 MWac or more, and C&I projects of the company are smaller-scale solar projects where the solar PV systems are installed on rooftops and are designed to generate electricity for commercial and industrial properties for their consumption at factories, warehouses, and commercial stores. The company derives its revenue from Malaysia.

Share on Social Networks: